{"id":"W2091938246","doi":"10.1016/j.ygyno.2004.03.020","title":"A phase II evaluation of Temozolomide in patients with recurrent epithelial ovarian cancer","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Temozolomide; Medicine; Toxicity; Ovarian cancer; Chemotherapy; Internal medicine; Ovarian carcinoma; Oncology; Phases of clinical research; Gastroenterology; Cancer; Surgery; Urology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001573094,0.0008987208,0.00241517,0.0003886714,0.000384641,0.0006490892,0.000662496,0.0008451677,0.001759881],"category_scores_gemma":[0.001129084,0.0004277299,0.001127201,0.0004419155,0.0008019109,0.0006420045,0.0003160055,0.002229573,0.0003378082],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001035821,"about_ca_system_score_gemma":0.001656407,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00291838,"about_ca_topic_score_gemma":0.006461543,"domain_scores_codex":[0.9994993,0.0002743167,0.00002509851,0.00006571512,0.00004211113,0.00009341284],"domain_scores_gemma":[0.9993654,0.0001325307,0.0001013899,0.00006184752,0.00004714089,0.0002916839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7163727,0.04883175,0.0172946,0.0009890452,0.001874057,0.0003527962,0.000656225,0.003155054,0.05132414,0.000304154,0.003162833,0.1556826],"study_design_scores_gemma":[0.4646034,0.5018574,0.02443461,0.00002905247,0.0007784365,0.0003948607,0.0001404297,0.001127762,0.003894791,0.00009485535,0.002616913,0.0000273847],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966086,0.001333491,0.0002289406,0.0002925557,0.00004892506,0.0006157116,0.0003740336,0.00002686908,0.0004708958],"genre_scores_gemma":[0.9936414,0.001827352,0.0009387374,0.0004076949,0.00008911955,0.0008085603,0.001194628,0.00001763162,0.001074913],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00291838,"threshold_uncertainty_score":0.008319438,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03612771182876882,"score_gpt":0.3612938308630818,"score_spread":0.3251661190343129,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}